Dupont Capital Management Corp Bristol Myers Squibb CO Transaction History

Dupont Capital Management Corp

$1.14 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $394,619 - $438,163	-6,194 Reduced 38.19%	10,026 $641,000
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $2.37 Million - $2.69 Million	-36,066 Reduced 68.98%	16,220 $1.12 Million
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $377,119 - $446,562	-5,507 Reduced 9.53%	52,286 $0
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $1,268 - $749,727	-9,757 Reduced 14.44%	57,793 $4.11 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $714,072 - $786,443	-9,833 Reduced 12.71%	67,550 $5.2 Million
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $1.44 Million - $1.73 Million	-23,410 Reduced 23.23%	77,383 $5.65 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $1.11 Million - $1.29 Million	-20,666 Reduced 17.01%	100,793 $6.28 Million
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $1.11 Million - $1.3 Million	-18,715 Reduced 13.35%	121,459 $7.19 Million
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $288,624 - $314,312	-4,662 Reduced 3.22%	140,174 $9.37 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $1.06 Million - $1.19 Million	17,874 Added 14.08%	144,836 $9.14 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $584,732 - $662,609	-10,127 Reduced 7.39%	126,962 $7.88 Million
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $1.12 Million - $1.24 Million	19,504 Added 16.59%	137,089 $8.27 Million
Q2 2020 Jul 24, 2020	BUY	$54.82 - $64.09 $2.76 Million - $3.23 Million	50,358 Added 74.91%	117,585 $6.91 Million
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $1.54 Million - $2.24 Million	-33,155 Reduced 33.03%	67,227 $3.75 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $1.46 Million - $1.9 Million	29,647 Added 41.91%	100,382 $6.44 Million
Q3 2019 Oct 28, 2019	SELL	$42.77 - $50.71 $2.06 Million - $2.45 Million	-48,268 Reduced 40.56%	70,735 $3.59 Million
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $214,399 - $237,078	-4,805 Reduced 3.88%	119,003 $5.4 Million
Q1 2019 Apr 30, 2019	BUY	$45.12 - $53.8 $669,625 - $798,445	14,841 Added 13.62%	123,808 $5.91 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $2.4 Million - $3.11 Million	-49,217 Reduced 31.11%	108,967 $5.66 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $341,184 - $384,829	-6,182 Reduced 3.76%	158,184 $9.82 Million
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $988,316 - $1.23 Million	19,559 Added 13.51%	164,366 $9.1 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $4.92 Million - $5.67 Million	82,184 Added 131.24%	144,807 $9.16 Million
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $1.03 Million - $1.12 Million	17,176 Added 37.79%	62,623 $3.84 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $2.51 Million - $2.9 Million	45,447	45,447 $2.9 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account